Combating the epidemic of opioid abuse—including prescription painkillers and, increasingly, heroin—requires a multi-pronged approach that involves reducing drug diversion, expanding delivery of existing treatments (including medication-assisted treatments), and development of new medications for pain that can augment our existing treatment arsenal. But another crucial component we must not forget is that people who abuse or are addicted to opioids need to be kept alive long enough that they can be treated successfully. In this, the drug naloxone has a large potential role to play.
Presents research-based principles of adolescent substance use disorder treatment; covers treatment for a variety of drugs including, illicit and prescription drugs, alcohol, and tobacco; presents settings and evidence-based approaches unique to treating adolescents.
Impresa en: enero del 2014 Actualizada en: enero del 2014
The epidemic of prescription opioid abuse in this country is linked partly to the dramatic rise in prescriptions for these medicines over the last two decades, as well as the fact that many clinicians are inadequately trained to safely treat pain in their patients. Most medical schools only offer a few hours of instruction in safe prescribing of opioids for pain management. A recent review showed that only 3% of U.S. medical schools offer integrated pain management courses.
Researchers found that 1 in 8 high school seniors had used a prescription opioid nonmedically, and 70 percent of these teens had compounded the attendant risk by co-ingesting an opioid with one or more other drugs. Nonmedical opioid use was significantly more prevalent among whites than among African Americans or Hispanics.
A new vaccine hindered the often-abused prescription opioids oxycodone and hydrocodone from entering the brain and suppressed one of the drugs’ signature central nervous system effects. The findings warrant continued development of the vaccine as a potential aid in the treatment of oxycodone and hydrocodone abuse and dependence.
Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will join President Bill Clinton, New York dignitaries, and college students from New York University for a panel discussion on prescription drug abuse.
People who use prescription opiates nonmedically are more likely to consider suicide than those who use these medications only appropriately or not at all. A recent NIDA-supported study also disclosed that the risk for suicidal thoughts remains elevated after cessation of use.
Fewer teens are using cigarettes, alcohol, and most illicit drugs, according to NIDA’s latest Monitoring the Future study. Troubling trends persist in marijuana use, however, and nonmedical prescription drug use remains a concern.